Upregulated endogenous TLR2 ligand versican was reported to induce the expression of membrane type 1 matrix-bound metalloproteinase (MT1-MMP) in GAMs which activates tumor-released MMP2 and of glioma cells, contributing to invasive and migratory behavior of glioma [115]. Here, TLR2 is linked to central nervous system cancer.